Company
ChinaHybio Pharmaceutical Co., Ltd. (longhua), China – FDA Inspections
Inspection records and compliance data for Hybio Pharmaceutical Co., Ltd. (longhua). 2 FDA inspections on record, last inspected December 05, 2025.
Company Profile
This profile covers Hybio Pharmaceutical Co., Ltd. (longhua) based in China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected November 3, 2023. Last inspected December 5, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 5, 2025 | Not classified | Human Drugs | 1298166 |
| November 3, 2023 | Not classified | Human Drugs | 1224382 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Yichang HEC ChangJiang Pharmaceutical Co Ltd
Tianjin Hope Technology Testing Co.,Ltd.
Shanghai Aucta Pharmaceuticals Co., Ltd.
Nanjing MilestonePharma Co. Ltd.
Jiangsu Yuanchuang Pharmaceutical Research and Development Co., Ltd. Analysis and Testing Branch
Sinotherapeutics Inc.
Seasons Biotechnology (Taizhou) Co., Ltd
Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd.
Shanghai WEIPU Testing Technology Group Co.,LTD.
Standard Sci-tech Innovation (Qingdao) Pharmaceutical Technology Co., Ltd.
Company Information
Name
Hybio Pharmaceutical Co., Ltd. (longhua)
FEI Number
3026377169
Address
China
Country
China
ID: 2b0b20d6-aed0-403f-819f-fe664b314d59